Online citations, reference lists, and bibliographies.
← Back to Search

PROGRESSIVE SUPRANUCLEAR PALSY. A HETEROGENEOUS DEGENERATION INVOLVING THE BRAIN STEM, BASAL GANGLIA AND CEREBELLUM WITH VERTICAL GAZE AND PSEUDOBULBAR PALSY, NUCHAL DYSTONIA AND DEMENTIA.

J. Steele, J. Richardson, J. Olszewski
Published 1964 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Introduction In this report we are describing a progressive brain disease featured by supranuclear ophthalmoplegia affecting chiefly vertical gaze, pseudobulbar palsy, dysarthria, dystonic rigidity of the neck and upper trunk, and other less constant cerebellar and pyramidal symptoms. Dementia has usually remained mild. This disease would appear to be predominantly a nerve cell degeneration centered chiefly in the brain stem. The fully developed clinical picture presented by this disease seems to follow a fairly definitive pattern and does not conform to the classical system degenerations such as motor neurone disease, paralysis agitans, cerebellar degeneration, Creuzfeldt-Jakob disease, or the presenile dementias. Yet it would seem unlikely that the disease shown by our cases is a new one, and similar earlier cases may well have been accepted as arteriosclerotic parkinsonism when that diagnosis was used in a very broad sense such as in Critchley's monograph of 1929. 1 There are some resemblances to
This paper references



This paper is referenced by
10.1111/j.1440-1819.1981.tb00215.x
Frequency of Alzheimer's Neurofibrillary Tangle in the Brains of Progressive Supranuclear Palsy, Postencephalitic Parkinsonism, Alzheimer's Disease, Senile Dementia and Non‐Demented Elderly Person
Y. Mitsuyama (1981)
10.1007/BF00236859
The effects of pretectal and superior collicular lesions on binocular vision
K. Lawler (2004)
10.1016/0013-4694(86)90153-7
EEG changes in subcortical dementia: a study of 22 patients with Steele-Richardson-Olszewski (SRO) syndrome.
C. Fowler (1986)
10.1007/978-94-009-3317-0_19
Oculomotor disturbances in extra-pyramidal disorders. A review of the literature
E. Bollen (1987)
10.1007/BF00618258
Progressive supranuclear palsy with lower motor neuron involvement
K. Sieradzan (2004)
10.1016/0022-510X(88)90063-9
Three categories of the degenerative appearance of the human cerebellar dentate nucleus: A morphometric and morphological study
N. Arai (1988)
10.1016/0304-3940(88)90759-8
Antigenic characteristics of neurofibrillary tangles in progressive supranuclear palsy
P. Galloway (1988)
10.1007/BF00688179
Pathology of the dentate nucleus in progressive supranuclear palsy: a histological, immunohistochemical and ultrastructural study
H. Mizusawa (2004)
10.1016/0022-510X(75)90171-9
Contribution to clinical pathology of progressive supranuclear palsy (subcortical argyrophilic dystrophy): On the distribution of neurofibrillary tangles in the basal ganglia and brain-stem and its clinical significance
H. Ishino (1975)
10.1007/978-3-7091-6892-9_2
Cytoskeletal pathology in non-Alzheimer degenerative dementia: new lesions in diffuse Lewy body disease, Pick's disease, and corticobasal degeneration.
D. Dickson (1996)
10.1007/s004010051033
Preferential neurodegeneration in the cervical spinal cord of progressive supranuclear palsy
H. Kikuchi (1999)
10.1002/cne.20744
The PDAPP mouse model of Alzheimer's disease: Locus coeruleus neuronal shrinkage
D. German (2005)
10.1111/j.1600-0404.1995.tb01694.x
Tomographic measurements of regional cerebral blood flow in progressive supranuclear palsy and Parkinson's disease
L. Defebvre (1995)
10.1111/j.1600-0404.2006.00767.x
Assessment of midbrain atrophy in patients with progressive supranuclear palsy with routine magnetic resonance imaging
M. Cosottini (2007)
10.1111/j.1600-0404.2007.00988.x
Transcranial magnetic stimulation for differential diagnostics in patients with parkinsonism
Y. Morita (2008)
10.1016/B978-012351830-9/50023-8
21 – Tau Phosphorylation
L. Buée (2001)
10.1001/ARCHNEUR.58.2.259
Progression of dysarthria and dysphagia in postmortem-confirmed parkinsonian disorders.
J. Müller (2001)
10.1017/CBO9780511544873.045
Progressive Supranuclear Palsy.
L. Golbe (2001)
10.1016/b978-012088382-0/50047-5
Genetic Susceptibility and Animal Modeling of PSP
Parvoneh Poorkaj Navas (2005)
10.1093/BRAIN/AWH488
Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism.
D. Williams (2005)
10.1016/S0246-0378(06)29334-5
Paralysie supranucléaire progressive (maladie de Steele-Richardson-Olszewski)
F. Dubas (2006)
10.1212/01.wnl.0000266667.91074.fe
A novel form of autosomal recessive hereditary spastic paraplegia caused by a new SPG7 mutation
T. Warnecke (2007)
10.1002/9783527610754.MD09
Protein Aggregates in Neurodegenerative Disorders
G. Giaccone (2008)
10.1007/BF03079574
Progressieve Supranucleaire Verlamming. Interventie middels acetylcholineesteraseremmer?
H. Nijboer (2009)
10.2169/INTERNALMEDICINE.50.5954
PSP as distinguished from CBD, MSA-P and PD by clinical and imaging differences at an early stage.
T. Kurata (2011)
10.1016/B978-1-4377-2369-4.00009-3
Chapter 9 – Atypical parkinsonism, parkinsonism-plus syndromes, and secondary parkinsonian disorders
S. Fahn (2011)
Sleep abnormalities intraumatic apallic syndrome
J. Faroni (2011)
10.1016/j.parkreldis.2013.02.005
Clinical and cognitive correlations of regional gray matter atrophy in progressive supranuclear palsy.
A. Giordano (2013)
10.1007/978-981-13-3681-2_4
Neurodegenerative Diseases and Ageing.
L. Walker (2019)
10.2217/nmt.15.37
The differentiation of progressive supranuclear palsy.
N. Cordato (2015)
10.1212/WNL.45.1.127
Alterations of GABAergic neurons in the basal ganglia of patients with progressive supranuclear palsy
R. Lévy (1995)
Magnetic Resonance Imaging in Parkinsons's disease and related disoders
Y. Surova (2018)
See more
Semantic Scholar Logo Some data provided by SemanticScholar